Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04050176 · ClinicalTrials.gov registry record · Phase 3
Use of Blinded Tapering for Hypnotic Discontinuation
A Phase 3 study of Hypnotic Dependence Among Those With Insomnia, sponsored by National Jewish Health.
- Active
- Registry status
- Phase 3
- Development phase
- 260
- Enrollment target
- 1
- Study location
NCT04050176 is a Phase 3 study of Hypnotic Dependence Among Those With Insomnia that is active but no longer recruiting, run by National Jewish Health. The registered enrollment target is 260 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04050176, a Phase 3 study of Hypnotic Dependence Among Those With Insomnia, is active but no longer recruiting, sponsored by National Jewish Health.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will employ a randomized longitudinal clinical trial design to evaluate the relative efficacy of a blinded hypnotic tapering protocol when used in combination with therapist delivered Cognitive Behavioral Therapy for Insomnia (CBTI) for enhancing hypnotic discontinuation rates. A blinded SMT+CBTI intervention will be compared to open-label SMT+CBTI.
Conditions Studied
Interventions
- BEHAVIORAL Hypnotic Medication Open-Label Taper
- BEHAVIORAL Hypnotic Medication Blinded Taper
Study Locations (1)
Colorado
- National Jewish Health - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2019-12-16 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04050176
The ClinicalTrials.gov registry entry for NCT04050176 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypnotic Dependence Among Those With Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Hypnotic Medication Open-Label Taper is the first listed.
NCT04050176 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04050176 about?
NCT04050176 is a clinical study titled "Use of Blinded Tapering for Hypnotic Discontinuation". The study will employ a randomized longitudinal clinical trial design to evaluate the relative efficacy of a blinded hypnotic tapering protocol when used in combination with therapist delivered Cognitive Behavioral Therapy for Insomnia (CBTI) for enhancing hypnotic discontinuation rates. A blinded S...
What is the current status of trial NCT04050176?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 260 participants. The study started on 2019-12-16. Estimated completion is 2026-06-30.
What conditions does trial NCT04050176 study?
This clinical trial studies the following conditions: Hypnotic Dependence Among Those With Insomnia.
What interventions are being tested in trial NCT04050176?
The interventions under investigation include: Hypnotic Medication Open-Label Taper (BEHAVIORAL), Hypnotic Medication Blinded Taper (BEHAVIORAL).
Who is sponsoring clinical trial NCT04050176?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04050176 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.